[HTML][HTML] Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study.
E Coates, N Wickramasekera, A Barr… - Health Technology …, 2022 - ncbi.nlm.nih.gov
Health Technology Assessment (Winchester, England), 2022•ncbi.nlm.nih.gov
BACKGROUND Corticosteroids are a mainstay of the treatment of moderately severe
relapses of ulcerative colitis, yet almost 50% of patients do not respond fully to these and risk
prolonged steroid use and side effects. There is a lack of clarity about the definitions of
steroid resistance, the optimum choice of treatment, and patient and health-care
professional treatment preferences. OBJECTIVES The overall aim of this research was to
understand how steroid-resistant ulcerative colitis is managed in adult secondary care and …
relapses of ulcerative colitis, yet almost 50% of patients do not respond fully to these and risk
prolonged steroid use and side effects. There is a lack of clarity about the definitions of
steroid resistance, the optimum choice of treatment, and patient and health-care
professional treatment preferences. OBJECTIVES The overall aim of this research was to
understand how steroid-resistant ulcerative colitis is managed in adult secondary care and …
Abstract
BACKGROUND
Corticosteroids are a mainstay of the treatment of moderately severe relapses of ulcerative colitis, yet almost 50% of patients do not respond fully to these and risk prolonged steroid use and side effects. There is a lack of clarity about the definitions of steroid resistance, the optimum choice of treatment, and patient and health-care professional treatment preferences.
OBJECTIVES
The overall aim of this research was to understand how steroid-resistant ulcerative colitis is managed in adult secondary care and how current practice compares with patient and health-care professional preferences.
DESIGN
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果